Drug Products Labeled as Homeopathic Guidance for FDA Staff and Industry
Posted: Tue Jan 30, 2018 5:37 pm
Drug Products Labeled as Homeopathic Guidance for FDA Staff and Industry
This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should be submitted within ___ days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit electronic comments to https://www.regulations.gov. Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number listed in the notice of availability that publishes in the Federal Register. For questions regarding this draft document contact the Center for Drug Evaluation and Research (CDER) at 301-796-2089 or the Office of Communication, Outreach and Development (CBER), 800-835-4709 or 240-402-8010.
https://www.fda.gov/downloads/Drugs/Gui ... 589373.pdf
Comments to be received by March 30,2018
Marilyn
This guidance document is being distributed for comment purposes only. Comments and suggestions regarding this draft document should be submitted within ___ days of publication in the Federal Register of the notice announcing the availability of the draft guidance. Submit electronic comments to https://www.regulations.gov. Submit written comments to the Dockets Management Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number listed in the notice of availability that publishes in the Federal Register. For questions regarding this draft document contact the Center for Drug Evaluation and Research (CDER) at 301-796-2089 or the Office of Communication, Outreach and Development (CBER), 800-835-4709 or 240-402-8010.
https://www.fda.gov/downloads/Drugs/Gui ... 589373.pdf
Comments to be received by March 30,2018
Marilyn